Home › Adocia › Olivier Soula

OS

Olivier Soula — 33 Patents

ADAdocia: 24 patents #1 of 21Top 5%

FTFlamel Technologies: 5 patents #8 of 39Top 25%

MTMonsanto Technology: 4 patents #942 of 1,728Top 55%

FLFlamel Ireland Limited: 1 patents #20 of 26Top 80%

Meyzieu, FR: #3 of 139 inventorsTop 3%

Overall (All Time): #105,480 of 4,157,543Top 3%

33 Patents All Time

Olivier Soula has been granted 33 US patents while listed as an inventor at Adocia. The first was granted in 2000 and the most recent in October 2020. Olivier Soula ranks #105,480 of 4,157,543 US inventors in our database (top 2.5%). Patent records list Olivier Soula in Meyzieu, FR.

Patents per Year

Issued Patents All Time

Showing 1–25 of 33 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
10792335	Rapid-acting insulin composition comprising a substituted citrate	Richard Charvet, Bertrand Alluis	2020-10-06
10583175	Rapid-acting insulin formulation comprising a substituted anionic compound	Gerard Soula, Emmanuel DAUTY, Richard Charvet	2020-03-10
10548952	Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals	Alexandre GEISSLER, Ségolène Laage, Richard Charvet	2020-02-04
10485851	Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid	Alexandre GEISSLER, Ségolène Laage, Richard Charvet, David Duracher, Gregory Meiffren	2019-11-26
10449256	Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer	Richard Charvet	2019-10-22
10383918	Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid	Alexandre GEISSLER, Ségolène Laage, David Duracher, Gregory Meiffren	2019-08-20
10383920	Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals	Alexandre GEISSLER, Ségolène Laage, Richard Charvet	2019-08-20
10335489	Injectable solution at pH 7 comprising at least one basal insulin the pi of which is between 5.8 and 8.5 and a substituted co-polyamino acid	—	2019-07-02
RE46686	Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications	Cecile Bonnet-Gonnet, David Chognot, Alain Constancis	2018-01-30
9795678	Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound	Richard Charvet, Bertrand Alluis	2017-10-24
9775355	Guanidine derivative compounds	Ronald J. Brinker, Alain Lemercier	2017-10-03	$27,057,000
9700599	Rapid-acting insulin formulation comprising a substituted anionic compound	Gerard Soula, Emmanuel DAUTY, Richard Charvet	2017-07-11
9492467	Rapid-acting insulin formulation comprising an oligosaccharide	Remi Soula, Gerard Soula	2016-11-15
9493583	Anionic polysaccharides functionalized by a hydrophobic acid derivative	Richard Charvet, Remi Soula	2016-11-15
9457089	Highly concentrated aqueous protein solution with reduced viscosity	—	2016-10-04
9233993	N-phosphonomethylglycine guanidine derivative salts	Ronald J. Brinker, Alain Lemercier	2016-01-12	$3,381,000
9198971	Injectable solution at pH 7 comprising at least one basal insulin the pI of which is between 5.8 and 8.5 and a substituted co-polyamino acid	—	2015-12-01
9115218	Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer	Richard Charvet, Remi Soula	2015-08-25
9089476	Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5	Gerard Soula, Jeff TONNAR, Alexandre GEISSLER	2015-07-28
9018190	Functionalized oligosaccharides	Richard Charvet, Remi Soula	2015-04-28
8679540	Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications	Cecile Bonnet-Gonnet, David Chognot, Alain Constancis	2014-03-25	$4,193,000
8669227	Fast-acting insulin formulation	Remi Soula, Gerard Soula	2014-03-11
8629124	Dextran functionalized by hydrophobic amino acids	Gerard Soula, Remi Soula	2014-01-14
8546356	Administration form of osteogenic protein complexes	Remi Soula, Gerard Soula	2013-10-01
8426382	Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative	Remi Soula, Gerard Soula, Richard Charvet	2013-04-23